×
Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Bioreactors Market Forecast 2028 By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By Product Type (Single-use, Reusable), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), By End-use (R&D Organizations, Biopharma Manufacturers, CMOs), Research Report, Country Outlook (U.S. Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: November 2022   |   Report ID: GR1222   |   Delivery: PDF  Request Free Sample

    Report Content

    Chapter 1   Methodology & Scope

    1.1    Definitions and forecast parameters

    1.1.1    Definitions

    1.1.2    Methodology and forecast parameters

    1.2    Data sources

    1.2.1    Secondary

    1.2.2    Primary

    Chapter 2   Executive Summary

    2.1    North America bioreactors industry summary, 2017-2028

    2.1.1    Country trends

    2.1.2    Product type trends

    2.1.3    Cell trends

    2.1.4    Molecule trends

    2.1.5    Usage trends

    2.1.6    End-user trends

    Chapter 3   Industry Insights

    3.1    Industry segmentation

    3.2    Industry landscape, 2017-2028 (USD Million)

    3.3    Major factor analysis

    3.3.1    Drivers

    3.3.1.1   Growing pharmaceutical and biotechnology industry in the region

    3.3.1.2   Rising government initiatives in the region

    3.3.1.3   Technological advancements in bioprocessing systems

    3.3.1.4   Rising demand for vaccines and cell-targeted therapies

    3.3.2    Industry pitfalls and challenges

    3.3.2.1   Limitations associated with single-use bioreactors

    3.3.2.2   Concerns regarding extractables and leachables

    3.3.2.3   Stringent regulatory framework

    3.4    Analysis of COVID-19 impact on the industry

    3.5    Porter’s analysis

    3.6    Competition review, 2021

    3.7    PEST analysis

    Chapter 4   North America Bioreactors Market, By Product Type

    4.1    Market trends

    4.2    Single use

    4.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    4.3    Reusable

    4.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 5   North America Bioreactors Market, By Cell

    5.1    Market trends

    5.2    Mammalian cells

    5.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    5.3    Bacterial cells

    5.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    5.4    Yeast cells

    5.4.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    5.5    Others

    5.5.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 6   North America Bioreactors Market, By Molecule

    6.1    Market trends

    6.2    Monoclonal antibodies

    6.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.3    Vaccines

    6.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.4    Recombinant proteins

    6.4.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.5    Stem cells

    6.5.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.6    Gene therapy

    6.6.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    6.7    Others

    6.7.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 7   North America Bioreactors Market, By Usage

    7.1    Market trends

    7.2    Developmental, pre-clinical & clinical

    7.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    7.3    Commercial production

    7.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 8   North America Bioreactors Market, By End-user

    8.1    Market trends

    8.2    R&D organizations

    8.2.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    8.3    Biopharma manufacturers

    8.3.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    8.4    Contract manufacturing organizations (CMOs)

    8.4.1    Market estimates and forecast, by country, 2017-2028 (USD Million)

    Chapter 9   North America Bioreactors Market, By Country

    9.1    Market trends

    9.2    U.S.

    9.2.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.2.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.2.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.2.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.2.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    9.3    Canada

    9.3.1    Market estimates and forecast, by product type, 2017-2028 (USD Million)

    9.3.2    Market estimates and forecast, by cell, 2017-2028 (USD Million)

    9.3.3    Market estimates and forecast, by molecule, 2017-2028 (USD Million)

    9.3.4    Market estimates and forecast, by usage, 2017-2028 (USD Million)

    9.3.5    Market estimates and forecast, by end-user, 2017-2028 (USD Million)

    Chapter 10   Company Profiles

    10.1    Applikon Biotechnology, Inc. (Getinge)

    10.1.1    Business overview

    10.1.2    Financial data

    10.1.3    Product landscape

    10.1.4    Strategic outlook

    10.2    Bbi-biotech

    10.2.1    Business overview

    10.2.2    Financial data

    10.2.3    Product landscape

    10.2.4    Strategic outlook

    10.3    Cellexus Limited

    10.3.1    Business overview

    10.3.2    Financial data

    10.3.3    Product landscape

    10.3.4    Strategic outlook

    10.4    CerCell Aps

    10.4.1    Business overview

    10.4.2    Financial data

    10.4.3    Product landscape

    10.4.4    Strategic outlook

    10.5    Eppendorf AG

    10.5.1    Business overview

    10.5.2    Financial data

    10.5.3    Product landscape

    10.5.4    Strategic outlook

    10.6    Cytiva (Danaher Corporation)

    10.6.1    Business overview

    10.6.2    Financial data

    10.6.3    Product landscape

    10.6.4    Strategic outlook

    10.7    GEA Group Aktiengesellschaft

    10.7.1    Business overview

    10.7.2    Financial data

    10.7.3    Product landscape

    10.7.4    Strategic outlook

    10.8    Merck Group

    10.8.1    Business overview

    10.8.2    Financial data

    10.8.3    Product landscape

    10.8.4    Strategic outlook

    10.9    Pierre Guerin SAS

    10.9.1    Business overview

    10.9.2    Financial data

    10.9.3    Product landscape

    10.9.4    Strategic outlook

    10.10    Sartorius Stedim Biotech Group

    10.10.1    Business overview

    10.10.2    Financial data

    10.10.3    Product landscape

    10.10.4    Strategic outlook

    10.11    Solaris Biotech Solutions

    10.11.1    Business overview

    10.11.2    Financial data

    10.11.3    Product landscape

    10.11.4    Strategic outlook

    10.12    Thermo Fisher Scientific Inc.

    10.12.1    Business overview

    10.12.2    Financial data

    10.12.3    Product landscape

    10.12.4    Strategic outlook

    10.13    Solida Biotech

    10.13.1    Business overview

    10.13.2    Financial data

    10.13.3    Product landscape

    10.13.4    Strategic outlook


    Get this research report on North America Bioreactors Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team

      (+1)-208-273-9852

     [email protected]